Skip to content

STTK

Shattuck Labs, Inc.

NASDAQ · USHealthcareBiotechnology
$6.82-9.43%

Price as of Jul 20, 2026

STTK capital

Shattuck Labs, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.03x
Net debt / equity
-0.91x
Debt / assets
0.03x
Debt / EBITDA
-0.06x
Net debt / EBITDA
1.89x

Liquidity & coverage

Current ratio
22.06x
Quick ratio
22.06x
Cash ratio
21.28x
Interest coverage
EBITDA / interest
Working capital
$89.5M

Cash & dividend

FCF / debt
-14.29x
Cash flow / debt
-14.29x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.